Delivery Order SPE2DB20D3101-SPE2DB22FH0G1
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $17,584.21 for the pharmaceutical product Trelegy Ellipta 200-62.5-25 60s. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of May 10, 2024. The contract is a firm fixed-price delivery order and was not set aside for any specific business type. Amerisourcebergen holds a significant $999,999,999 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $5,016.40, is for the delivery of Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product. The award has a performance period through February 12, 2024 and is a Firm Fixed Price Delivery Order contract. The contract was not set aside for any specific business type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,417.89 firm-fixed-price delivery order is for the pharmaceutical product Trelegy Ellipta 100-62.5-25 60S. The contract has an ultimate completion date of May 16, 2023. This order is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a wide range of pharmaceutical products and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $15,841.68 delivery order contract is for the supply of Trelegy Ellipta 200-62.5-25 60S, a pharmaceutical product. The contract has an ultimate completion date of October 16, 2023 and utilizes a firm fixed price pricing type. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $31,532.68, is a Delivery Order for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of March 12, 2025. Amerisourcebergen Drug Corp is a for-profit corporate entity registered in the System for Award...
- This federal contract award, valued at $15,940.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product. The contract has an ultimate completion date of November 8, 2023 and was awarded on November 7, 2023. This is a firm fixed-price delivery order contract, without any set-aside designation. Amerisourcebergen Drug Corp is a major...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,253.54 firm-fixed-price delivery order is for the pharmaceutical product Trelegy Ellipta 100-62.5-25 60S. The contract has an ultimate completion date of July 13, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. Cencora, Inc. holds a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DB22FN74S) valued at $5,539.01 for the pharmaceutical product Trelegy Ellipta 100-62.5-25 60S. The contract was awarded on March 7, 2022 by the Defense Logistics Agency (DLA), a component of the Department of Defense, with an ultimate completion date of March 8, 2022. Amerisourcebergen is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award, valued at $14,876.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, which does not have a set-aside designation, is a Delivery Order for the pharmaceutical product Trelegy Ellipta 100-62.5-25 60S. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the...
- This federal contract award, valued at $20,437.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order with a Firm Fixed Price for the pharmaceutical product Trelegy Ellipta 100-62.5-25 60S. The award has an ultimate completion date of September 27, 2023. The contract is not designated with a set-aside requirement, indicating full and open competition. Amerisourcebergen Drug Corp holds a significant...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB22FH0G1Delivery Order
This federal contract award, valued at $3,705.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and subsidiary of Cencora, Inc. The contract is for the delivery of Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product, and has an ultimate completion date of October 26, 2021. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and was awarded on October 25, 2021. It does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 10/25/21 |